KRRO – korro bio, inc. (US:NASDAQ)
Stock Stats
News
Korro Bio, Inc. (NASDAQ: KRRO) had its price target lowered by analysts at HC Wainwright from $115.00 to $100.00. They now have a "buy" rating on the stock.
Korro Bio, Inc. (NASDAQ: KRRO) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $120.00 price target on the stock.
Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer
Otolith Labs Rounds Out Executive Team with Appointment of Kevin Franck, PhD, MBA as Chief Clinical Officer [Yahoo! Finance]
Korro Announces $70 Million Private Placement
Form 3 Korro Bio, Inc. For: May 13 Filed by: Olugemo Olukemi
Form S-1 Korro Bio, Inc.
Form 424B3 Korro Bio, Inc.
Form 10-Q Korro Bio, Inc. For: Mar 31
Form 8-K Korro Bio, Inc. For: May 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.